relugolix

Relugolix (737789-87-6) Relugolix is a highly selective, oral, nonpeptide GnRH antagonist being investigated as a potential prostate cancer treatment. Product Name Relugolix CAS No. 737789-87-6 Assay 99% Specification CP, EP, In-house, as required Molecular Formula C29H27F2N7O5S Molecular Weight 623.63 Shelf Life 2 Years Package 25kg/drum